Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kinnate Biopharma Inc.
| -13.72M |
—
|
—
| -100.00% |
0
|
Apr 3
| |||||||
Pardes Biosciences, Inc.
| -16.81M |
—
|
—
| -99.99% | 1K |
Aug 31
| |||||||
Theseus Pharmaceuticals, Inc.
| 700K |
$2.97 | $2,079,000.00 | +14.60% | 5.49M |
Jul 17
| |||||||
Pardes Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Kinnate Biopharma Inc.
| 1.78M |
$2.80 | $4,984,000.00 | +78.53% | 4.05M |
May 8
| |||||||
Pardes Biosciences, Inc.
| 773.95K |
$1.50 | $1,160,928.00 | +9.68% | 8.77M |
Apr 5
| |||||||
Pardes Biosciences, Inc.
| 773.95K |
$1.50 | $1,160,928.00 | +6.04% | 13.58M |
Apr 5
| |||||||
Kinnate Biopharma Inc.
| 1.1M |
—
|
—
| +125.71% | 1.98M |
Feb 17
| |||||||
Theseus Pharmaceuticals, Inc.
| 500K |
$5.00 | $2,500,000.00 | +11.64% | 4.79M |
Dec 29
| |||||||
Pardes Biosciences, Inc.
| 637.42K |
$0.85 | $541,807.00 | +5.24% | 12.81M |
Dec 1
| |||||||
Kinnate Biopharma Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Theseus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Pardes Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Pardes Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 23
| |||||||
Pardes Biosciences, Inc.
| 4.94M |
—
|
—
|
∞
| 4.94M |
Dec 23
| |||||||
Pardes Biosciences, Inc.
| 13.63M |
$10.00 | $10,000,000.00 |
∞
| 13.63M |
Dec 23
| |||||||
FS Development Corp. II
| 325K |
$10.00 | $3,250,000.00 |
∞
| 325K |
Dec 22
| |||||||
Aclaris Therapeutics, Inc.
| -1.95M |
—
|
—
| -99.58% | 8.28K |
Nov 1
| |||||||
Gemini Therapeutics, Inc. /de
|
0
|
—
|
—
|
—
|
0
|
Oct 4
| |||||||
Quantum-Si Inc
| 8.42M |
$7.82 | $12,500,348.13 |
∞
| 8.42M |
Jun 10 - Jun 11
| |||||||
Quantum-Si Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
FS Development Corp. II
| 602.5K |
$10.00 | $6,025,000.00 |
∞
| 602.5K |
Feb 19
| |||||||
FS Development Corp. II
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Gemini Therapeutics, Inc. /de
| 4.43M |
$10.00 | $15,000,000.00 |
∞
| 4.43M |
Feb 5
| |||||||
Kinnate Biopharma Inc.
| 9.84M |
—
|
—
| +983.83% | 10.84M |
Dec 7
| |||||||
Kinnate Biopharma Inc.
| 1M |
$20.00 | $20,000,000.00 |
∞
| 1M |
Dec 3
| |||||||
Kinnate Biopharma Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 2
| |||||||
Kinnate Biopharma Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
FS Development Corp.
| 441.5K |
$10.00 | $4,415,000.00 |
∞
| 441.5K |
Aug 14
| |||||||
FS Development Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
FS Development Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
10x Genomics, Inc.
| 480.2K |
$80.13 | -$116,188,500.00 | +8.94% | 5.85M |
May 12 - May 13
| |||||||
10x Genomics, Inc.
| 2M |
—
|
—
| +59.35% | 5.37M |
May 6
| |||||||
10x Genomics, Inc.
| 392.26K |
—
|
—
| +14.67% | 3.07M |
Apr 22 - Apr 23
| |||||||
10x Genomics, Inc.
| 387.81K |
—
|
—
| +13.29% | 3.3M |
Apr 13 - Apr 14
| |||||||
10x Genomics, Inc.
| 2.17M |
—
|
—
| +1,157.66% | 2.36M |
Mar 24
| |||||||
10x Genomics, Inc.
| 559K |
$59.00 | -$44,250,000.00 | +15.36% | 4.2M |
Mar 4 - Mar 18
| |||||||
Aerie Pharmaceuticals Inc
| -1.00M |
$17.07 | -$17,070,000.00 | -18.10% | 4.52M |
Feb 27
| |||||||
Aerie Pharmaceuticals Inc
| 28.9K |
$30.00 | $867,000.00 | +1.96% | 1.5M |
Dec 20
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.